ARTICLE | Financial News

Vital raises $54 million in IPO

April 16, 2014 11:44 PM UTC

Liver disease company Vital Therapies Inc. (NASDAQ:VTL) raised $54 million through the sale of 4.5 million shares at $12 in an IPO underwritten by BofA Merrill Lynch; Credit Suisse; William Blair; and Canaccord. The price values Vital at $253.4 million. The share price is below the range set earlier this month, when the company said it planned to 4.5 million shares at $13-$15. Vital is slated to start trading on Thursday. ...